FI852804L - Farmaceutiska preparat med reglerbar utloesning. - Google Patents
Farmaceutiska preparat med reglerbar utloesning.Info
- Publication number
- FI852804L FI852804L FI852804A FI852804A FI852804L FI 852804 L FI852804 L FI 852804L FI 852804 A FI852804 A FI 852804A FI 852804 A FI852804 A FI 852804A FI 852804 L FI852804 L FI 852804L
- Authority
- FI
- Finland
- Prior art keywords
- registration
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63197984A | 1984-07-18 | 1984-07-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI852804A0 FI852804A0 (fi) | 1985-07-17 |
| FI852804L true FI852804L (fi) | 1986-01-19 |
Family
ID=24533574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI852804A FI852804L (fi) | 1984-07-18 | 1985-07-17 | Farmaceutiska preparat med reglerbar utloesning. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0171528A3 (fi) |
| JP (1) | JPH0649645B2 (fi) |
| KR (1) | KR920007568B1 (fi) |
| AU (1) | AU571659B2 (fi) |
| CA (1) | CA1236023A (fi) |
| DK (1) | DK324385A (fi) |
| FI (1) | FI852804L (fi) |
| NO (1) | NO852880L (fi) |
| NZ (1) | NZ211449A (fi) |
| PH (1) | PH20391A (fi) |
| ZA (1) | ZA853462B (fi) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0248051A1 (en) * | 1985-11-29 | 1987-12-09 | FISONS plc | Pharmaceutical composition including sodium cromoglycate |
| IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
| NZ219925A (en) * | 1986-07-30 | 1989-06-28 | Pennwalt Corp | Polymer-treated sulphonic acid cationic exchange resin particles |
| US4859462A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Polymer-treated ion exchange resins |
| US4859461A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Coatable ion exchange resins |
| US4895723A (en) * | 1986-09-08 | 1990-01-23 | Amer And Company | Cholestyramine compositions and method for preparation thereof |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| US5186930A (en) * | 1988-11-14 | 1993-02-16 | Schering Corporation | Sustained release oral suspensions |
| US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
| US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
| IT1241417B (it) | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
| AU8050791A (en) * | 1990-06-20 | 1992-01-07 | Advanced Polymer Systems Inc. | Compositions and methods for the controlled release of soluble active substances |
| WO1992011038A1 (en) * | 1990-12-21 | 1992-07-09 | Richardson-Vicks Inc. | Polyamine drug-resin complexes |
| JP3278192B2 (ja) * | 1992-04-03 | 2002-04-30 | ロート製薬株式会社 | 徐放性液剤 |
| US5350584A (en) * | 1992-06-26 | 1994-09-27 | Merck & Co., Inc. | Spheronization process using charged resins |
| US20060083759A1 (en) * | 2002-07-17 | 2006-04-20 | Aleksander Resman | Stabilization of the profile of release of active substances from a formulation |
| CA2509429A1 (en) | 2002-11-26 | 2004-06-10 | University Of Maryland, Baltimore | Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| WO2006135362A1 (en) * | 2005-06-09 | 2006-12-21 | Upm Pharmaceuticals, Inc. | Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| US9238078B2 (en) | 2009-04-03 | 2016-01-19 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
| ES2470940B1 (es) * | 2012-12-21 | 2015-04-16 | Laboratorios Rubió, S.A. | Aducto entre un poliol y una resina de intercambio iónico |
| ES2471340B1 (es) | 2012-12-21 | 2015-08-17 | Laboratorios Rubió, S.A. | Composición farmacéutica oral para fármacos de elevada posología |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
| DE2246037B2 (de) * | 1972-09-20 | 1975-02-27 | Taeschner & Co, 8831 Kipfenberg | Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform |
| NZ185772A (en) * | 1976-11-26 | 1978-12-18 | Pennwalt Corp | A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
-
1985
- 1985-02-26 CA CA000475154A patent/CA1236023A/en not_active Expired
- 1985-03-07 AU AU39635/85A patent/AU571659B2/en not_active Ceased
- 1985-03-14 NZ NZ211449A patent/NZ211449A/en unknown
- 1985-03-26 PH PH32053A patent/PH20391A/en unknown
- 1985-05-08 ZA ZA853462A patent/ZA853462B/xx unknown
- 1985-05-30 EP EP85106695A patent/EP0171528A3/en not_active Withdrawn
- 1985-06-03 JP JP60119001A patent/JPH0649645B2/ja not_active Expired - Lifetime
- 1985-07-17 DK DK324385A patent/DK324385A/da not_active Application Discontinuation
- 1985-07-17 FI FI852804A patent/FI852804L/fi not_active Application Discontinuation
- 1985-07-18 KR KR1019850005111A patent/KR920007568B1/ko active IP Right Grant
- 1985-07-18 NO NO852880A patent/NO852880L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK324385D0 (da) | 1985-07-17 |
| JPS6130514A (ja) | 1986-02-12 |
| EP0171528A2 (en) | 1986-02-19 |
| FI852804A0 (fi) | 1985-07-17 |
| AU3963585A (en) | 1986-01-23 |
| ZA853462B (en) | 1985-12-24 |
| JPH0649645B2 (ja) | 1994-06-29 |
| KR860000865A (ko) | 1986-02-20 |
| PH20391A (en) | 1986-12-10 |
| NO852880L (no) | 1986-01-20 |
| NZ211449A (en) | 1987-08-31 |
| EP0171528A3 (en) | 1986-04-23 |
| DK324385A (da) | 1986-01-19 |
| AU571659B2 (en) | 1988-04-21 |
| CA1236023A (en) | 1988-05-03 |
| KR920007568B1 (ko) | 1992-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI852804L (fi) | Farmaceutiska preparat med reglerbar utloesning. | |
| FI860559A0 (fi) | 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
| NO880410D0 (no) | Oralt preparat. | |
| DE3681348D1 (de) | Oral-arzneizubereitung mit retardwirkung. | |
| FI862094A0 (fi) | Bornerande terapeutisk komposition. | |
| DE3580304D1 (de) | Arzneimittel. | |
| NO166391C (no) | Preparat for motvirkning av daarlig aande. | |
| FI854573A0 (fi) | Farmaceutiska kapslar med foerdroejd frigoering. | |
| NO860725L (no) | Deres fremstilling. | |
| FI872733A0 (fi) | Farmaceutiska kompositioner. | |
| DE3669105D1 (de) | Therapeutische zusammensetzung. | |
| FI865101A0 (fi) | Anordning foer registrering av beroering. | |
| FI872313A0 (fi) | Farmaceutiska kompositioner. | |
| FI822187A0 (fi) | Farmaceutiska preparat | |
| FI883673A (fi) | Farmaceutiska kompositioner. | |
| IT1213453B (it) | Composizione farmaceutica. | |
| NO864722D0 (no) | Tokomponents herdbart preparat. | |
| FI874382A0 (fi) | Farmaceutiska preparat. | |
| FI852658A0 (fi) | Farmaceutiska aemnen. | |
| FI883747A (fi) | Topiskt anvaendbara farmaceutiska preparat. | |
| IT8520591A0 (it) | Formulazione farmaceutica. | |
| NO159131C (no) | Preparat for tiltrekning av margborere. | |
| DE3667915D1 (de) | Pharmazeutische zusammensetzung. | |
| NO871780D0 (no) | Medisinsk preparat. | |
| IT8520272A0 (it) | Composizione farmaceutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: PENNWALT CORPORATION |